4Filed May 6, 8:00 PM ET

Provectus (PVCT) CEO Edward Pershing Converts Note into Preferred

$PVCT · PROVECTUS BIOPHARMACEUTICALS, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

Provectus (PVCT) CEO Edward Pershing Converts Note into Preferred

What Happened
Edward (Ed) Pershing, CEO and director of Provectus Biopharmaceuticals (PVCT), converted an outstanding 8% unsecured convertible promissory note (the "2025 Note") into 18,876 shares of Series D‑1 Convertible Preferred Stock on May 7, 2026. The Form 4 lists the acquisition at $0.00 per share because this was a debt-to-equity conversion rather than a cash purchase. At the stated conversion price of $2.862 per Series D‑1 share, the conversion implies roughly $54,000 of principal/interest was converted into preferred stock.

Key Details

  • Transaction date: 2026-05-07 (reported on Form 4 filed 2026-05-07 — timely).
  • Reported transaction code(s): M (exercise/conversion of a derivative); filing shows one disposal line (N/A) and one acquisition of 18,876 Series D‑1 shares at $0.00.
  • Conversion mechanics: The 2025 Note converted into 18,876 shares of Series D‑1 Preferred (per filing footnote F4). The conversion price used for the note was $2.862 per Series D‑1 share (footnote F3).
  • Common-equivalent: Each Series D‑1 Preferred is convertible into 10 shares of common stock (footnote F1), so these 18,876 preferred shares equate to 188,760 common shares if converted.
  • Automatic conversion: Series D‑1 will automatically convert to common stock on Dec 31, 2028 unless earlier converted under the Certificate of Designation (footnote F2).
  • Shares owned after transaction: Not specified in the provided Form 4 data.

Context
This was a conversion of debt to preferred equity (a financing/structural transaction) rather than an open-market buy or sale. The Form 4 shows the acquisition price as $0.00 because the exchange was made in satisfaction of the promissory note rather than by paying cash. For investors, note the preferred shares carry a 10:1 conversion to common and will automatically convert at a future date (or possibly earlier under the certificate terms), so the economic impact depends on future conversion and company actions rather than an immediate change in common‑share float.